# Evaluating the Value of FDA Pre-Submission Meetings: Are They Worth the Time? The U.S. Food and Drug Administration (FDA)...

**Evaluating the Value of FDA Pre-Submission Meetings** In the complex and highly regulated world of medical device and pharmaceutical development,...

**Evaluating the Effectiveness of FDA Pre-Submission Meetings** The U.S. Food and Drug Administration (FDA) plays a pivotal role in ensuring...

**Implementing Shift Left Strategies in Software as a Medical Device (SaMD) Development: An Informative Webinar** In the rapidly evolving landscape...

**The Growing Importance of Cybersecurity in Healthcare: Addressing an Evolving Challenge** In recent years, the healthcare industry has undergone a...

# The Critical Importance of Cybersecurity in Healthcare: Addressing an Evolving Challenge In an era where digital transformation is revolutionizing...

**The Growing Importance of Cybersecurity in Healthcare: Addressing an Ongoing Challenge** In recent years, the healthcare industry has undergone a...

**New Pacemaker for Heart Failure Recovery Receives Trial Approval – Medical Device News Magazine** In a groundbreaking development for cardiovascular...

**Medical Device News Magazine Announces Approval of New Pacemaker Trial Designed to Enhance Heart Failure Recovery** In a groundbreaking development...

**Medical Device News Magazine: New Pacemaker Receives Trial Approval to Enhance Heart Failure Recovery** In a groundbreaking development for cardiology,...

**Medical Device News Magazine Announces Trial Approval for Innovative Pacemaker Designed to Enhance Heart Failure Recovery** *October 2023 – Medical...

**New Pacemaker Receives Trial Approval to Enhance Recovery in Heart Failure Patients** *Medical Device News Magazine – October 2023* In...

**NMPA Evaluates Registration of PD-L1 Screening Assay: A Step Forward in Precision Oncology** The National Medical Products Administration (NMPA) of...

**NMPA Reviewers Evaluate Registration of PD-L1 Screening Assay: A Critical Step in Precision Oncology** In the rapidly evolving landscape of...

# Nationwide Implementation of Urgent Use Policy for Medical Devices: Expanding Beyond Hainan and Greater Bay Area ## Introduction In...

**Nationwide Implementation of Urgent Use Policy for Medical Devices, Extending Beyond Hainan and the Greater Bay Area** In recent years,...

# Nationwide Implementation of Urgent Use Policy for Medical Devices: Expanding Beyond Hainan and the Greater Bay Area ## Introduction...

**Nationwide Implementation of Urgent Use Policy for Medical Devices: Expanding Beyond Hainan and the Greater Bay Area** In recent years,...

**Fulgent Genetics Achieves Record Patent Filings and Grants in April 2024, Leading Q2 Performance** In a remarkable display of innovation...

**Fulgent Genetics Achieves Record Number of Patent Filings and Grants in April 2024, Leading Q2 Performance** In a remarkable display...

**Fulgent Genetics Achieves Record Patent Filings and Grants in April of Q2 2024** In a remarkable stride forward in the...

**Title: Pioneering AI Technology in Prostate Cancer Diagnosis: A New Era for UK Hospital Systems** **Introduction** In a groundbreaking move,...

**Three UK Hospital Systems Test AI Technology for Prostate Cancer Diagnosis in Clinical Settings – Reports Paige, Medical Device News...

**Three UK Hospital Systems Test AI for Prostate Cancer Diagnosis in Clinical Settings – Medical Device News Magazine Reports** In...

**The Role of Technology in Enhancing Personalized Brain Health and Improving Outcomes: Insights from Mark Lehmkuhle, PhD, CEO and Founder...

# Common Materials and Devices in Medical Device Manufacturing Medical device manufacturing is a highly specialized field that requires stringent...

**HeartFlow Launches Advanced Interactive Plaque Analysis Platform for Evaluating Patient Risk in Suspected Coronary Artery Disease** *Medical Device News Magazine*...

# A Look Inside Canary Wharf’s Advanced Infectious Disease Testing Facility In the heart of London’s bustling financial district, Canary...

**Bon Secours Mercy Health and Philips Announce Long-Term Strategic Partnership** In a significant move poised to reshape the landscape of...

**Bon Secours Mercy Health and Philips Announce Multi-Year Strategic Partnership** *Medical Device News Magazine* In a significant move poised to...

Genesis MedTech and Silk Road Medical Partner to Improve Healthcare Access for Patients with Carotid Artery Disease in China

Genesis MedTech, a leading medical technology company, has recently announced a partnership with Silk Road Medical to improve healthcare access for patients with carotid artery disease in China. This collaboration aims to provide innovative solutions for the treatment of this common and potentially life-threatening condition.

Carotid artery disease occurs when the arteries in the neck become narrowed or blocked, restricting blood flow to the brain. This can lead to serious complications such as stroke, which is a major cause of disability and death worldwide. In China, the prevalence of carotid artery disease is on the rise due to factors such as an aging population and increasing rates of obesity and diabetes.

Genesis MedTech and Silk Road Medical are joining forces to address this growing healthcare challenge by offering advanced treatment options for patients in China. Silk Road Medical is known for its minimally invasive technology, including the TransCarotid Artery Revascularization (TCAR) procedure, which has been shown to be safer and more effective than traditional surgical methods.

Through this partnership, Genesis MedTech will distribute Silk Road Medical’s TCAR devices in China, making this cutting-edge technology more accessible to patients in need. This will allow healthcare providers in China to offer a less invasive and more efficient treatment option for carotid artery disease, ultimately improving patient outcomes and reducing healthcare costs.

In addition to providing innovative medical devices, Genesis MedTech and Silk Road Medical are committed to supporting healthcare professionals in China through training and education programs. By equipping doctors with the knowledge and skills to perform TCAR procedures, this partnership will help to ensure that patients receive the highest quality care possible.

Overall, the collaboration between Genesis MedTech and Silk Road Medical represents a significant step forward in improving healthcare access for patients with carotid artery disease in China. By combining their expertise and resources, these two companies are working together to make a positive impact on the lives of patients and their families. With their shared commitment to innovation and excellence, Genesis MedTech and Silk Road Medical are poised to make a lasting difference in the field of vascular medicine in China and beyond.